Investment
Features
FeesSafety
Academy
More
Pluang+

Compare FedEx Corporation (FDX) vs Novartis AG (NVS) Price & Performance

FedEx CorporationTrade
Novartis AGTrade

Price performance (Past 24H)

Key statistics

FedEx Corporation vs Novartis AG — how do they compare? FedEx Corporation trades at $322.99 (market cap $76.28B), while Novartis AG trades at $152.4 (market cap $295.37B). The key difference: Novartis AG is far larger — about 3.9× FedEx Corporation's market cap, and Novartis AG pays the higher dividend (3.07%). Which is the better fit depends on your goals.

FDXNVS
Market Cap
$76.28B$295.37B
Sector
IndustrialsHealth
52-Week High
$338.75$168.62
52-Week Low
$180.51$119.31
Enterprise Value
$105.91B$336.69B
Dividend Yield
1.51%3.07%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About FedEx Corporation

FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.

Read more on FDX

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS